Trial Profile
An Open-Label Drug Interaction Study to Investigate the Effects of Steady State Fenofibric Acid on the Single-Dose Pharmacokinetics of Efavirenz in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Fenofibric-acid (Primary)
- Indications HIV-1 infections; Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors URL Pharma
- 27 Aug 2009 New trial record